Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Khadiza Chowdhury"'
Publikováno v:
Lasers in Surgery and Medicine. 52:207-217
Background and objectives Successful outcomes of clinical studies for acne vulgaris depend greatly on achieving statistically significant reduction in acne lesion count and improvement in Investigator's Global Assessment score of the investigational
Publikováno v:
Procedia Engineering. 212:801-808
An accelerated wave of urbanization and the rapid population growth are brutally transmuting the urban fabric of Dhaka city, Bangladesh. These rampant growth combined with climatic changes are triggering an increase in vulnerability of communities to
Autor:
Khadiza Chowdhury, Yoon Jin Jang, David R. Goodlett, Young Ah Goo, Seung Young Seo, Mohd M. Khan, Han-Jung Chae, Soo Hyun Park, Bao Q. Tran, William E. Fondrie, Sung Hwan Yoon, Soo Wan Chae
Publikováno v:
Molecules and Cells
Dietary supplements have exhibited myriads of positive health effects on human health conditions and with the advent of new technological advances, including in the fields of proteomics, genomics, and metabolomics, biological and pharmacological acti
Autor:
Maria R. Baer, Eun Yong Choi, Nidal E Muvarak, Zeba N. Singh, Michael M. Seidman, Pratik K. Nagaria, Tyler Rutherford, Feyruz V. Rassool, Søren M. Bentzen, Rena G. Lapidus, Limin Xia, Yi Cai, Ying Zou, Marina A. Bellani, Stephen B. Baylin, Khadiza Chowdhury, Vu H. Duong, Carine Robert
Poly (ADP-ribose) polymerase inhibitors (PARPis) are clinically effective predominantly for BRCA-mutant tumors. We introduce a mechanism-based strategy to enhance PARPi efficacy based on DNA damage-related binding between DNA methyltransferases (DNMT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b439e03d8623240be3321961e7b1af7f
https://europepmc.org/articles/PMC5201166/
https://europepmc.org/articles/PMC5201166/
Autor:
Stephen B. Baylin, Khadiza Chowdhury, Maria R. Baer, Yi Cai, Xia Limin, Nidal Muvarak, Carine Robert, Feyruz V. Rassool, Marina A. Bellani, Eun Yong Choi, Rena G. Lapidus, Michael M. Seidman
Publikováno v:
Cancer Research. 77:IA13-IA13
Poly (ADP-ribose) polymerase (PARP) inhibitors represent one of the most exciting recent developments in cancer therapy. While substantial efficacy has been shown with clinically available PARP inhibitors (PARPis), to date, in treatment of hereditary
Autor:
Eun Yong Choi, Carine Robert, Pratik K. Nagaria, Maria R. Baer, Nidal Muvarak, Feyruz V. Rassool, Rena G. Lapidus, Stephen B. Baylin, Khadiza Chowdhury, Ashkan Emadi, Vu H. Duong
Publikováno v:
Cancer Research. 75:2848-2848
We present here strong preclinical data for a novel, mechanistically based, combinatorial approach to using DNA methyltransferase inhibitors (DNMTi’s), such as decitabine (DAC) and 5-Azacytidine (AzaC), with PARP inhibitors (PARPi’s) as a treatme
Publikováno v:
Cancer Research. 75:2948-2948
Poly-ADP-ribose polymerase inhibitors (PARPis) represent one of the most exciting recent developments in cancer therapy and have shown efficacy in a minority (5-10%) of triple negative (estrogen, progesterone and herceptin receptor negative) breast c
Publikováno v:
Cancer Research. 73:1778-1778
Approximately 10-20% of breast cancers lack estrogen, progesterone or HER2 receptors, the so-called triple negative breast cancer cells (TNBCs). These women have a poor prognosis and treatment options are limited. Therefore, the development of novel